Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Virus Infections

Explore clinical trials studying Respiratory Syncytial Virus Infections. Study availability and eligibility vary by location and protocol.

144 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Virus Infections trial results

Completed

A Phase III Study to Assess the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response and Safety of RSV Maternal Vaccine When Given Alone or Co-administered With GSK's Influenza D-QIV Vaccine in Healthy Non-pregnant Women.

NCT05045144

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site West Palm Beach, Florida, United States
  • GSK Investigational Site Stockbridge, Georgia, United States
  • GSK Investigational Site Peoria, Illinois, United States
  • GSK Investigational Site Springfield, Missouri, United States
View all 36 locations
View Trial Details
Completed

A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children

NCT03959488

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Research Site Anaheim, California, United States
  • Research Site Long Beach, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site National City, California, United States
View all 128 locations
View Trial Details
Completed

A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV Surveillance

NCT03614676

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Villanueva- Guaymallen, Mendoza Province, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Mendoza, Argentina
View all 40 locations
View Trial Details
Completed

A Study of 3 Lots of an Investigational Vaccine Against Respiratory Syncytial Virus (RSV) in Adults Aged 60 Years and Above

NCT05059301

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Waterbury, Connecticut, United States
  • GSK Investigational Site Brooksville, Florida, United States
  • GSK Investigational Site Immokalee, Florida, United States
  • GSK Investigational Site Buford, Georgia, United States
View all 19 locations
View Trial Details
Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

NCT03814590

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Jacksonville, Florida, United States
  • GSK Investigational Site Miami, Florida, United States
  • GSK Investigational Site Stockbridge, Georgia, United States
  • GSK Investigational Site Lenexa, Kansas, United States
View all 21 locations
View Trial Details

Related conditions